BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei D, Hu MJ, Shao XX, Wang JH, Nie WH, Liu YL, Xu ZG, Guo ZY. Development of a selective agonist for relaxin family peptide receptor 3. Sci Rep 2017;7:3230. [PMID: 28607363 DOI: 10.1038/s41598-017-03465-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Lin G, Feng Y, Cai X, Zhou C, Shao L, Chen Y, Chen L, Liu Q, Zhou Q, Bathgate RAD, Yang D, Wang MW. High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist. Molecules 2021;26:7511. [PMID: 34946593 DOI: 10.3390/molecules26247511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lin L, Lin G, Zhou Q, Bathgate RAD, Gong GQ, Yang D, Liu Q, Wang MW. Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists. Bioorg Chem 2021;110:104782. [PMID: 33730669 DOI: 10.1016/j.bioorg.2021.104782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Li HZ, Li N, Shao XX, Liu YL, Xu ZG, Guo ZY. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay. Biochimie 2020;177:117-26. [PMID: 32810565 DOI: 10.1016/j.biochi.2020.08.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 DeChristopher B, Park SH, Vong L, Bamford D, Cho HH, Duvadie R, Fedolak A, Hogan C, Honda T, Pandey P, Rozhitskaya O, Su L, Tomlinson E, Wallace I. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration. Bioorg Med Chem Lett 2019;29:991-4. [PMID: 30824200 DOI: 10.1016/j.bmcl.2019.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
5 Wang JH, Shao XX, Hu MJ, Liu YL, Xu ZG, Guo ZY. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5. Amino Acids 2019;51:619-26. [PMID: 30604098 DOI: 10.1007/s00726-018-02694-y] [Reference Citation Analysis]
6 Wang JH, Hu MJ, Zhang L, Shao XX, Lv CH, Liu YL, Xu ZG, Guo ZY. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids. Biochimie 2018;154:77-85. [PMID: 30102931 DOI: 10.1016/j.biochi.2018.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Hu MJ, Shao XX, Li HZ, Nie WH, Wang JH, Liu YL, Xu ZG, Guo ZY. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation. Amino Acids 2018;50:1111-9. [PMID: 29770870 DOI: 10.1007/s00726-018-2588-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
8 Wang JH, Hu MJ, Shao XX, Wei D, Liu YL, Xu ZG, Guo ZY. Cholesterol modulates the binding properties of human relaxin family peptide receptor 3 with its ligands. Arch Biochem Biophys 2018;646:24-30. [PMID: 29601823 DOI: 10.1016/j.abb.2018.03.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Hossain MA, Bathgate RAD. Challenges in the design of insulin and relaxin/insulin-like peptide mimetics. Bioorg Med Chem 2018;26:2827-41. [PMID: 28988628 DOI: 10.1016/j.bmc.2017.09.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]